b-rayZ proudly secures the CE mark for DANAI, an industry-first Custom AI technology embedded in the b-box plus suite. DANAI, set to launch at ECR 2024, dynamically adapts to diverse clinical environments, enhancing diagnostic…
Continue Reading
What You Should Know: – Rad AI, an AI startup revolutionizing radiology reporting is teaming up with Google to tackle radiologists’ workload and elevate patient care. – The strategic alliance leverages Google Cloud’s AI…
Continue Reading
By Shania Kennedy
January 09, 2024 – A research team from the Icahn School of Medicine at Mount Sinai has developed an artificial intelligence (AI) tool to help predict which cardiovascular patients are at increased risk…
Continue Reading
Qure.ai, a trailblazer in medical imaging solutions, celebrates its 13th FDA clearance with qXR-LN, an AI-powered tool for lung nodule detection. This pioneering technology signifies Qure.ai’s supremacy in AI-driven advancements for plain film radiography…
Continue Reading
A new partnership between healthcare tech provider AiOne Healthcare Technologies Ltd and AI tech company DeepTek.ai is set to enhance diagnostic accuracy within AI-powered medical imaging analysis and streamline workflow for healthcare providers. AiOne…
Continue Reading
Exo’s 2023 Survey Report unveils barriers hindering widespread POCUS adoption, highlighting infrastructure gaps and the potential impact of AI. Handheld devices offer promise in underserved areas, while AI integration promises streamlined imaging. Primary care…
Continue Reading
Enlitic and Infinitt join forces, integrating Endex data standardization into Infinitt’s PACS. This collaboration targets medical imaging data standardization, leveraging AI technology to enhance radiology workflow efficiency. It resolves interoperability issues, ensuring consistency, reliability,…
Continue Reading
AI revolutionizes healthcare through precise medical imaging, AI-assisted surgeries, accelerated research, drug development, and early disease detection. Remote patient care, fraud prevention, accurate cancer diagnosis, and gene editing are redefining healthcare standards. Collaboration between…
Continue Reading
The emergence of artificial intelligence (AI) in healthcare is the result of increased demand for tailored healthcare solutions, lower costs, higher accuracy pertaining to medical decisions and diagnosis to improve patient health outcomes. With an…
Continue Reading
Lunit’s acquisition of Volpara at AUD 1.15 per share marks a pivotal move in cancer diagnostics. The Scheme Implementation Agreement targets Volpara’s AI-enabled solutions, expanding Lunit’s global presence. Volpara’s 100 million mammogram images promise…
Continue Reading
